tiprankstipranks
Bluejay Diagnostics Announces CFO Change and Stockholders’ Meeting Date
Company Announcements

Bluejay Diagnostics Announces CFO Change and Stockholders’ Meeting Date

Don't Miss Our Christmas Offers:

Bluejay Diagnostics (BJDX) has issued an announcement.

Bluejay Diagnostics, Inc. has ended its agreement with DLA, LLC, leading to the departure of Interim CFO Frances Scally. The company’s CEO, Neil Dey, will take over as the principal financial and accounting officer. Additionally, Bluejay announced that its 2024 annual stockholders’ meeting is scheduled for May 14, with April 3 set as the record date for stockholder voting eligibility.

Learn more about BJDX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyBluejay Diagnostics Inc trading halted, news pending
TheFlyBluejay Diagnostics announces 1-for-50 reverse stock split
TheFlyBluejay Diagnostics announces pricing of $8.75M underwritten public offering
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App